Improved accuracy in prostate cancer treatment
Swedish company Micropos Medical has developed a novel system to make prostate cancer treatment faster, safer and more targeted.
Micropos Medical is a Swedish company...
Cutting-edge nanotechnology could lead to Alzheimer’s disease test
A group of scientists have used cutting-edge nanotechnology to extract blood signal of neurodegeneration, which they hope could enable a test for early Alzheimer’s...
Clinical trial launched for Type 1 Diabetes medication
A Phase II clinical trial that will test the efficacy of a medication for Type 1 Diabetes has been initiated.
Adocia, a clinical stage biopharmaceutical...
COVID-19 Variant of Concern has been found in England
There have been two more cases of a COVID-19 Variant of Concern identified in England.
Two cases of the COVID-19 variant known as VOC-21JAN-02 (P.1)...
Predicting long-term outcomes for pre-invasive breast cancer
New research has presented a new and more accurate method of predicting long-term outcomes for ductal carcinoma and has confirmed the role of the...
Skin swabs could be sufficient for detecting COVID-19
New research has demonstrated that non-invasive skin swabs could be sufficient for detecting COVID-19.
A team of researchers at the University of Surrey have teamed...
People with underlying conditions encouraged to get COVID-19 vaccine
UK health charities are encouraging anyone with an underlying health condition to come forward for a COVID-19 vaccine.
A number of UK charities have penned...
World-first test for diagnosing and monitoring Parkinson’s Disease
A team of scientists has developed a new method that offers the hope of developing a ‘game changing’ test that could diagnose and monitor...
AOP Orphan: a European pioneer in the field of rare and complex diseases
AOP Orphan optimises the patient experience with integrated therapy solutions combining drugs, medical devices, and empathic care.
Austria-based company AOP Orphan Pharmaceuticals AG has been...
Analysis shows 99.9% accuracy of lateral flow tests for COVID-19
A new analysis has shown that lateral flow device tests for COVID-19 have an accuracy of 99.9% with an extremely low rate of false...
Pathology and cancer diagnostic services
Royal College of Pathologists President Dr Michael Osborn speaks to Health Europa about the role of pathology in cancer diagnostic services.
Examining the neurological impacts of COVID-19
Dr Rhys Thomas of the COVID-19 Clinical Neuroscience Study’s research team tells HEQ about the neurological damage caused by COVID-19 and the need for...
Subcommittee reviews flu-like illness in COVID-19 vaccinated individuals
A review of reports from several different countries of influenza-like illness in individuals that have been vaccinated against COVID-19 have been reviewed by the...
Global Breast Cancer Initiative launched to reduce mortality
Today, on International Women’s Day, the World Health Organization (WHO) has launched its new Global Breast Cancer Initiative which aims to reduce global breast...
Clinical study shows natural formulation reduces endometriosis pain
A clinical study has shown successful results in the reduction of endometriosis pain from a natural formulation of trace-metals.
The clinical trial explored the efficacy...
COVID-19 impact on brain could cause mental health problems
A new review has found that a large portion of COVID-19 survivors will be affected by neuropsychiatric and cognitive complications, which could have major...
Uncovered mechanism may provide new therapeutic strategy for epilepsy
A team of researchers has suggested that a future therapeutic strategy could be aimed at controlling the function of glial cells to treat epilepsy.
In...
Diffusion-weighted imaging could reduce biopsies in breast cancer screenings
A simple MRI measurement of the breast could reduce the biopsy rate in breast cancer screenings by 30%, a study has revealed.
T cells key to severity of COVID-19 outcomes
A new study has suggested that a balanced T cell response to COVID-19 is vital in helping the immune system effectively fight the virus,...
Protein kinase inhibitors could offer a new HIV treatment option
A new study shows that protein kinases, enzymes that initiate the process that erodes the body’s immunity, are partly responsible for immunodeficiency in HIV patients. The findings will help explore new treatment options for the condition.
